These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7927133)

  • 1. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion associated graft versus host disease.
    Anwar M; Bhatti FA
    J Ayub Med Coll Abbottabad; 2003; 15(3):56-8. PubMed ID: 14727344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
    Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
    Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-associated graft-versus-host disease: an overview and two case reports.
    Spector D
    Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Prevention of graft-vs.-host disease.
    Woods WG
    Am J Pediatr Hematol Oncol; 1984; 6(3):283-6. PubMed ID: 6393792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
    Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
    J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products.
    Mintz PD; Wehrli G
    Bone Marrow Transplant; 2009 Aug; 44(4):205-11. PubMed ID: 19617907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of graft-versus-host disease following irradiated fresh blood transfusion].
    Mishima A; Takeuchi Y; Ueda N; Sato M; Terada J; Kamiya Y; Okubo T; Usami S; Kotani H; Suzuki Y
    Kyobu Geka; 1991 Sep; 44(10):825-7. PubMed ID: 1920999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature.
    Decoste SD; Boudreaux C; Dover JS
    Arch Dermatol; 1990 Oct; 126(10):1324-9. PubMed ID: 2221937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case.
    Utkan G; Buyukcelik A; Demir O; Sanli H; Pamir A
    Acta Med Austriaca; 2003; 30(5):138-41. PubMed ID: 15055161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for irradiated blood components: dose and side effects].
    Eiermann TH
    Beitr Infusionsther; 1993; 31():70-3. PubMed ID: 7693267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion associated graft versus host disease.
    Gupta A; Bansal D; Dass R; Das A
    Indian Pediatr; 2004 Dec; 41(12):1260-4. PubMed ID: 15623910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-associated graft-versus-host disease.
    Rappeport JM
    Yale J Biol Med; 1990; 63(5):445-54. PubMed ID: 2293503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease.
    Corash L; Lin L
    Bone Marrow Transplant; 2004 Jan; 33(1):1-7. PubMed ID: 14647263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
    Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
    Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
    Weiss B; Hoffmann M; Anders C; Hellstern P; Schmitz N; Uppenkamp M;
    Ann Hematol; 2004 Jan; 83(1):44-9. PubMed ID: 14551741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.